Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

Cyclin A1 Expression and Regulation in Hematopoietic and Leukemic Cells

  • Jenny Ekberg
Publiceringsår: 2006
Språk: Engelska
Sidor: 110
Publikation/Tidskrift/Serie: Lund University, Faculty of Medicine Doctoral Dissertation Series 2006-30
Dokumenttyp: Doktorsavhandling
Förlag: KFSAB Lund
Ytterligare information: J Ekberg, G Landberg, C Holm, J Richter, D Wolgemuth and J Liao Persson. 2004. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells. Oncogene,, vol 2;23 pp 9082-9. J Ekberg, S Jalili, C Holm, J Richter, L Anagnostaki, G Landberg and J Liao Persson. 2005. Expression of cyclin A1 and cell cycle regulatory proteins in hematopoietic progenitors and acute myeloid leukemia and links to disease relapse and survival. European Journal of Haematology, vol 75 pp 106-15. J Ekberg, C Brunhoff, M Järås, X Fan, G Landberg and J Liao Persson. . Increased expression of cyclin A1 protein is correlated with all-trans retinoic acid-induced apoptosis. International Journal of Biochemistry & Cell Biology, (accepted) J Ekberg, C Brunhoff, E Diffner, G Landberg and J Liao Persson. . Posttranslational modification of cyclin A1 is associated with staurosporine and TNFalpha induced apoptosis in leukemic cells. (manuscript)


Increased expression of the cell cycle regulatory protein cyclin A1 has previously been detected in patients with acute myeloid leukemia (AML) and targeted overexpression of cyclin A1 in a transgenic mouse model initiated AML. The aim of this thesis was to further study the expression and regulation of cyclin A1 in hematopoietic cells. We started with evaluating the subcellular localization of cyclin A1 and found that the protein was localized to the nucleus of normal early hematopoietic cells while it had a cytoplasmic localization in leukemic bone marrow cells as well as in leukemic cell lines. We further found that treatment with all-trans retinoic acid (ATRA) resulted in nuclear localization of cyclin A1 in U-937 cells and in the formation of complex between cyclin A1, CDK1 and RAR?. Our results indicate that the cytoplasmic localization of cyclin A1 correlates with a leukemic phenotype. Next we continued with analyzing the clinical relevance of the increased cyclin A1 expression in 40 AML patients. We found that patients with high levels of cyclin A1 had a significantly worse overall survival and a significantly lower disease-free survival compared to patients with low levels of cyclin A1. We continued with analyzing the correlation between cyclin A1 and drug induced apoptosis. Induction of apoptosis using ATRA, staurosporine and TNF? resulted in significantly increased cyclin A1 protein levels in contrast to decreased levels of other cell cycle regulatory proteins. Interestingly, the increased protein levels did not result from increased protein synthesis but was rather a result from decreased ubiquitination and degradation. Further, upon overexpression of cyclin A1 a significant increased amount of apoptotic cells was found. Our results also suggest that there is an association between the post-translational modifications of cyclin A1 protein and the induction of apoptosis by therapeutic agents.


Main lecture hall, Pathology building, entrance 78, Malmö University Hospital, Malmö
  • Fredrik Öberg (Docent)


  • Cell and Molecular Biology
  • Cancer and Oncology
  • cancer
  • General pathology
  • pathological anatomy
  • Patologi (allmän)
  • patologisk anatomi
  • onkologi
  • Cytologi
  • cancerology
  • oncology
  • Cytology
  • AML
  • cyclin A1
  • apoptosis
  • cell cycle regulation


  • Jenny L Persson
  • Göran Landberg
  • ISSN: 1652-8220
  • ISBN: 91-85481-55-6

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen